BioWorld Science

Nov. 26, 2020

View Archived Issues

City of Hope begins phase I testing of investigational SARS-CoV-2 vaccine COH-04S1

Read More

Altimmune submits IND application with the FDA for phase I study of AdCOVID

Read More

Equillium decides not to start phase III study of itolizumab for COVID-19

Read More

Kinnate Biopharma patents Raf kinase inhibitors

Read More

Constellation Pharmaceuticals synthesizes TREX1 inhibitors

Read More

Aclaris Therapeutics identifies new JAK inhibitors

Read More

Incyte synthesizes CDK2/cyclin E inhibitors

Read More

Bluebird bio divulges non-natural T cells for cancer

Read More

InMed reports results from an initial phase I trial of INM-755 healthy subjects

Read More

FDA grants accelerated approval to Danyelza for neuroblastoma

Read More

Chinese approval for phase I/II study of ATG-016 for MDS

Read More

ICT presents a novel CoupledCAR technology against colorectal cancer

Read More

Health Canada approves Lynparza as treatment of BRCA or ATM gene-mutated mCRPC

Read More

MetrioPharm plans to conduct a phase II study of MP-1032 in patients with COVID-19

Read More

Karyopharm presents phase III data from SEAL study of Xpovio in liposarcoma

Read More

Targeting lung metastases is EASI way to induce systemic immunity

Read More

ADG-2: preclinical results of a neutralizing antibody for human SARS-CoV-2

Read More

FDA proposes conduct of additional exploratory analyses for omaveloxolone in Friedreich's ataxia

Read More

Senhwa files INDs in U.S. and Canada to study CX-5461 for solid tumors with BRCA2 or PALB2 mutations

Read More

Phase I data presented for rCSP-based malaria vaccine

Read More